LYTIR

Company · FLNA

Filana Therapeutics, Inc.

Name as listed on its exchange; filed with the SEC as FILANA THERAPEUTICS, INC.

Nasdaq's symbol directory lists FLNA on Nasdaq as “Filana Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($356K); 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Barry Richard, President & CEO bought on 3 days latest Sep 30, 2026 bought $356K
Every trade (3)
  1. BUYBarry Richard, President & CEO bought Sep 30, 2026 100,000 shares filing $92K
  2. BUYBarry Richard, President & CEO bought Sep 29, 2026 206,813 shares filing $186K
  3. BUYBarry Richard, President & CEO bought Sep 28, 2026 93,091 shares filing $78K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026
  2. Other events filing Oct 20, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.